Technical Analysis for GHDX - Genomic Health, Inc.

Grade Last Price % Change Price Change
grade D 74.57 0.46% 0.34
GHDX closed up 0.46 percent on Tuesday, March 19, 2019, on 1.56 times normal volume. It ran into resistance at its 50 day moving average.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Up Down Flat
See historical GHDX trend table...

Date Alert Name Type % Chg
Mar 19 50 DMA Resistance Bearish 0.00%
Mar 18 50 DMA Resistance Bearish 0.46%
Mar 18 Doji - Bullish? Reversal 0.46%
Mar 15 Fell Below 50 DMA Bearish 0.09%
Mar 15 Volume Surge Other 0.09%
Mar 14 NR7 Range Contraction -2.54%
Mar 13 Pocket Pivot Bullish Swing Setup -1.88%
Mar 13 Volume Surge Other -1.88%
Mar 13 Oversold Stochastic Weakness -1.88%
Mar 12 Oversold Stochastic Weakness -0.41%

Older signals for GHDX ...

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Genomic Health, Inc., a healthcare company, provides actionable genomic information to personalize cancer treatment decisions. It develops and commercializes genomic-based clinical laboratory services that analyze the underlying biology of cancer, allowing physicians and patients to make individualized treatment decisions. The company provides the Oncotype DX invasive breast cancer test that is used for early stage invasive breast cancer patients to predict the likelihood of breast cancer recurrence and the likelihood of chemotherapy benefit. It also offers the Oncotype DX colon cancer test, which is used to predict the likelihood of colon cancer recurrence in patients with stage II disease, as well as for use in patients with stage III disease treated with oxaliplatin-containing adjuvant therapy. In addition, the company provides the Oncotype DX tests for patients with ductal carcinoma in situ, a pre-invasive form of breast cancer. Genomic Health, Inc. was founded in 2000 and is headquartered in Redwood City, California.
Medicine Cancer Healthcare Clinical Medicine Treatment Of Cancer Chemotherapy Breast Cancer Colorectal Cancer Cancer Treatment
Is GHDX a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 92.18
52 Week Low 30.04
Average Volume 405,470
200-Day Moving Average 65.5156
50-Day Moving Average 75.271
20-Day Moving Average 76.434
10-Day Moving Average 74.631
Average True Range 2.6216
ADX 26.44
+DI 15.0369
-DI 25.033
Chandelier Exit (Long, 3 ATRs ) 78.8352
Chandelier Exit (Short, 3 ATRs ) 79.9098
Upper Bollinger Band 81.6765
Lower Bollinger Band 71.1915
Percent B (%b) 0.32
BandWidth 13.717717
MACD Line -0.5194
MACD Signal Line -0.1814
MACD Histogram -0.338
Fundamentals Value
Market Cap 2.57 Billion
Num Shares 34.5 Million
EPS -0.15
Price-to-Earnings (P/E) Ratio -497.13
Price-to-Sales 3.41
Price-to-Book 6.72
PEG Ratio -149.73
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 77.29
Resistance 3 (R3) 77.29 76.39 76.83
Resistance 2 (R2) 76.39 75.70 76.39 76.68
Resistance 1 (R1) 75.48 75.27 75.03 75.48 76.53
Pivot Point 74.58 74.58 74.36 74.58 74.58
Support 1 (S1) 73.67 73.89 73.22 73.67 72.61
Support 2 (S2) 72.77 73.46 72.77 72.46
Support 3 (S3) 71.86 72.77 72.31
Support 4 (S4) 71.86